{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:57:03Z","timestamp":1764331023265},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1245\/s10434-020-08242-x","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T17:02:44Z","timestamp":1581526964000},"page":"2487-2497","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prognostic Impact of Curative Resection for Peritoneal Recurrence of Colorectal Cancer"],"prefix":"10.1245","volume":"27","author":[{"given":"Ken","family":"Imaizumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,12]]},"reference":[{"key":"8242_CR1","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00595-013-0735-x","volume":"44","author":"H Ozawa","year":"2014","unstructured":"Ozawa H, Kotake K, Kobayashi H, et al. Prognostic factors for peritoneal carcinomatosis originating from colorectal cancer: an analysis of 921 patients from a multi-institutional database. Surg Today. 2014;44:1643\u201350.","journal-title":"Surg Today"},{"key":"8242_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/DCR.0000000000000412","volume":"58","author":"P Quere","year":"2015","unstructured":"Quere P, Facy O, Manfredi S, et al. Epidemiology, management, and survival of peritoneal carcinomatosis from colorectal cancer: a population-based study. Dis Colon Rectum. 2015;58:743\u201352.","journal-title":"Dis Colon Rectum."},{"key":"8242_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ejso.2013.10.001","volume":"40","author":"YR van Gestel","year":"2014","unstructured":"van Gestel YR, Thomassen I, Lemmens VE, et al. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer. Eur J Surg Oncol. 2014;40:963\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"8242_CR4","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1245\/s10434-016-5732-z","volume":"24","author":"H Nagata","year":"2017","unstructured":"Nagata H, Ishihara S, Hata K, et al. Survival and prognostic factors for metachronous peritoneal metastasis in patients with colon cancer. Ann Surg Oncol. 2017;24:1269\u201380.","journal-title":"Ann Surg Oncol."},{"key":"8242_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/DCR.0000000000001002","volume":"61","author":"S Mayanagi","year":"2018","unstructured":"Mayanagi S, Kashiwabara K, Honda M, et al. Risk factors for peritoneal recurrence in stage II to III colon cancer. Dis Colon Rectum. 2018;61:803\u20138.","journal-title":"Dis Colon Rectum."},{"issue":"18_suppl","key":"8242_CR6","doi-asserted-by":"publisher","first-page":"LBA3503","DOI":"10.1200\/JCO.2018.36.18_suppl.LBA3503","volume":"36","author":"F Quenet","year":"2018","unstructured":"Quenet F, Elias D, Roca L, et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol. 2018;36(18_suppl):LBA3503.","journal-title":"J Clin Oncol."},{"key":"8242_CR7","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ejso.2013.03.003","volume":"39","author":"YL Klaver","year":"2013","unstructured":"Klaver YL, Lemmens VE, de Hingh IH. Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis. Eur J Surg Oncol. 2013;39:734\u201341.","journal-title":"Eur J Surg Oncol."},{"key":"8242_CR8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s00595-015-1254-8","volume":"46","author":"H Sato","year":"2016","unstructured":"Sato H, Toyama K, Koide Y, et al. Prognoses and treatment strategies for synchronous peritoneal dissemination of colorectal carcinoma. Surg Today. 2016;46:860\u201371.","journal-title":"Surg Today."},{"key":"8242_CR9","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17:1709\u201319.","journal-title":"Lancet Oncol."},{"key":"8242_CR10","unstructured":"Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal, appendiceal, and anal carcinoma, third English edition. Tokyo: Kanehara & Co., Ltd.; 2019."},{"key":"8242_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res."},{"key":"8242_CR12","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1245\/s10434-009-0866-x","volume":"17","author":"TC Chua","year":"2010","unstructured":"Chua TC, Morris DL, Esquivel J. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17:1330\u20136.","journal-title":"Ann Surg Oncol."},{"key":"8242_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant."},{"key":"8242_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"key":"8242_CR15","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1245\/s10434-006-9215-5","volume":"14","author":"MS Tsai","year":"2007","unstructured":"Tsai MS, Su YH, Ho MC, et al. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol. 2007;14:786\u201394.","journal-title":"Ann Surg Oncol."},{"key":"8242_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.clcc.2013.11.008","volume":"13","author":"R Kumar","year":"2014","unstructured":"Kumar R, Price TJ, Beeke C, et al. Colorectal cancer survival: an analysis of patients with metastatic disease synchronous and metachronous with the primary tumor. Clin Colorectal Cancer. 2014;13:87\u201393.","journal-title":"Clin Colorectal Cancer."},{"key":"8242_CR17","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.ejso.2005.06.002","volume":"31","author":"AL Bloemendaal","year":"2005","unstructured":"Bloemendaal AL, Verwaal VJ, van Ruth S, et al. Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study. Eur J Surg Oncol. 2005;31:1145\u201351.","journal-title":"Eur J Surg Oncol."},{"key":"8242_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/1471-2407-10-689","volume":"10","author":"JO Pelz","year":"2010","unstructured":"Pelz JO, Chua TC, Esquivel J, et al. Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin. BMC Cancer. 2010;10:689.","journal-title":"BMC Cancer."},{"key":"8242_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/COC.0b013e3182438c55","volume":"36","author":"YL Klaver","year":"2013","unstructured":"Klaver YL, Leenders BJ, Creemers GJ, et al. Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin. Am J Clin Oncol. 2013;36:157\u201361.","journal-title":"Am J Clin Oncol."},{"key":"8242_CR20","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737\u201343.","journal-title":"J Clin Oncol."},{"key":"8242_CR21","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284\u201392.","journal-title":"J Clin Oncol."},{"key":"8242_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63\u20138.","journal-title":"J Clin Oncol."},{"key":"8242_CR23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/jso.23728","volume":"110","author":"A Prada-Villaverde","year":"2014","unstructured":"Prada-Villaverde A, Esquivel J, Lowy AM, et al. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with mitomycin C versus oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol. 2014;110:779\u201385.","journal-title":"J Surg Oncol."},{"key":"8242_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/01.sla.0000197702.46394.16","volume":"243","author":"MJ Koppe","year":"2006","unstructured":"Koppe MJ, Boerman OC, Oyen WJ, et al. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg. 2006;243:212\u201322.","journal-title":"Ann Surg."},{"key":"8242_CR25","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s00535-013-0820-3","volume":"49","author":"H Kobayashi","year":"2014","unstructured":"Kobayashi H, Kotake K, Funahashi K, et al. Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis. J Gastroenterol. 2014;49:646\u201354.","journal-title":"J Gastroenterol."},{"key":"8242_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1245\/s10434-017-6133-7","volume":"25","author":"D Shida","year":"2018","unstructured":"Shida D, Tsukamoto S, Ochiai H, et al. Long-term outcomes after R0 resection of synchronous peritoneal metastasis from colorectal cancer without cytoreductive surgery or hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2018;25:173\u20138.","journal-title":"Ann Surg Oncol."},{"key":"8242_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ejso.2004.01.017","volume":"30","author":"CP Carmignani","year":"2004","unstructured":"Carmignani CP, Ortega-Perez G, Sugarbaker PH. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer. Eur J Surg Oncol. 2004;30:391\u20138.","journal-title":"Eur J Surg Oncol."},{"key":"8242_CR28","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1245\/ASO.2005.01.010","volume":"12","author":"D Elias","year":"2005","unstructured":"Elias D, Liberale G, Vernerey D, et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol. 2005;12:900\u20139.","journal-title":"Ann Surg Oncol."},{"key":"8242_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/SLA.0b013e3182778089","volume":"258","author":"L Maggiori","year":"2013","unstructured":"Maggiori L, Go\u00e9r\u00e9 D, Viana B, et al. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study. Ann Surg. 2013;258:116\u201321.","journal-title":"Ann Surg."},{"key":"8242_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejso.2016.09.010","volume":"43","author":"G Lorimier","year":"2017","unstructured":"Lorimier G, Linot B, Paillocher N, et al. Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer. Eur J Surg Oncol. 2017;43:150\u20138.","journal-title":"Eur J Surg Oncol."},{"key":"8242_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/915078","author":"PH Sugarbaker","year":"2011","unstructured":"Sugarbaker PH. Second-look surgery for colorectal cancer: revised selection factors and new treatment options for greater success. Int J Surg Oncol. 2011. https:\/\/doi.org\/10.1155\/2011\/915078.","journal-title":"Int J Surg Oncol."},{"key":"8242_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/SLA.0b013e31822638f6","volume":"254","author":"D Elias","year":"2011","unstructured":"Elias D, Honor\u00e9 C, Dumont F, et al. Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis. Ann Surg. 2011;254:289\u201393.","journal-title":"Ann Surg."},{"key":"8242_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","volume":"16","author":"JL Koh","year":"2009","unstructured":"Koh JL, Yan TD, Glenn D, et al. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2009;16:327\u201333.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08242-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-020-08242-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08242-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T14:06:01Z","timestamp":1613052361000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-020-08242-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,12]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["8242"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08242-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,12]]},"assertion":[{"value":"5 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}